News & Updates

Show Multimedia Only

Are pregnant women with rheumatic disease at risk of poor COVID-19 outcomes?

20 Jan 2022 by

Pregnant women with rheumatic disease and COVID-19 show favourable outcomes, but data are limited by the small sample size and methodology, reports a study.

20 Jan 2022

Epstein-Barr virus may be the initial trigger for MS

20 Jan 2022 by

Epstein-Barr virus (EBV) may be the first trigger for the development of multiple sclerosis (MS) in most cases, says an expert.

20 Jan 2022

Synovitis linked to constant pain in knee OA

19 Jan 2022

Moderate to severe synovitis is significantly associated with constant pain in patients with knee osteoarthritis (OA), reveals a study.

19 Jan 2022

Anxiety, depressive symptoms in JIA tied to pain, stress

19 Jan 2022

Moderate to severe symptoms of anxiety and depression have been reported in about one-fourth of children with juvenile idiopathic arthritis (JIA), according to a study. Such symptoms are associated with pain and stress, but not with other disease manifestations.

19 Jan 2022

$Tocilizumab effective in refractory joint, skin involvement in systemic sclerosis$

Tocilizumab effective in refractory joint, skin involvement in systemic sclerosis

18 Jan 2022

Interleukin-6 inhibition by tocilizumab (TCZ) leads to improvements in refractory joint and skin involvement regardless of systemic sclerosis (SSc) disease duration or subtype, reports a study.

18 Jan 2022

What factors predispose patients to hyperuricaemia following favipiravir treatment?

16 Jan 2022

An already elevated serum uric acid level at baseline and achievement of high steady-state serum favipiravir concentrations during therapy contribute to an increased risk of developing treatment-induced hyperuricaemia, according to a study.

16 Jan 2022

Add-on duloxetine exerts null effect on chronic osteoarthritis pain

12 Jan 2022

Adding duloxetine to usual care does not appear to produce significant relief from chronic osteoarthritis pain as compared with usual care alone, a study has found.

12 Jan 2022

COVID-19 vaccines safe for patients with rheumatic, musculoskeletal disease

11 Jan 2022

Vaccines against SARS-CoV-2 has a safety profile that is similar in patients with inflammatory/autoimmune rheumatic and musculoskeletal disease (I-RMD) and those with noninflammatory RMD (NI-RMD), according to a study. The vaccines are well tolerated with rare reports of I-RMD flare and serious adverse events.

11 Jan 2022

Original New Drug Application Approvals by US FDA (16 - 31 December 2021)

06 Jan 2022

New drug applications approved by US FDA as of 16-31 December 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

06 Jan 2022

Which domains are included in the core set for axial spondyloarthritis?

15 Dec 2021

Several domains that should be taken into account for the core outcome set of axial spondyloarthritis (axSpA) have been selected by patients and axSpA experts, reports a study.

15 Dec 2021

News & Updates

Showing Rheumatology articles

Showing

Specialty:

Are pregnant women with rheumatic disease at risk of poor COVID-19 outcomes?

Epstein-Barr virus may be the initial trigger for MS

Synovitis linked to constant pain in knee OA

Anxiety, depressive symptoms in JIA tied to pain, stress

Tocilizumab effective in refractory joint, skin involvement in systemic sclerosis

What factors predispose patients to hyperuricaemia following favipiravir treatment?

Add-on duloxetine exerts null effect on chronic osteoarthritis pain

COVID-19 vaccines safe for patients with rheumatic, musculoskeletal disease

Original New Drug Application Approvals by US FDA (16 - 31 December 2021)

Which domains are included in the core set for axial spondyloarthritis?